Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Stereotactic cisternal lavage with urokinase and nimodipine in aneurysmal subarachnoid hemorrhage
DRKS00015645Phase 2Recruiting
- Sponsor
- Universitätsklinikum Freiburg
- Start
- May 2019
- Modality
- Therapeutic Enzymes → Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of urokinase and nimodipine in subarachnoid hemorrhage (SAH) (2 arms), sponsored by Universitätsklinikum Freiburg. Started May 2019; status: recruiting.
02
Drugs
urokinasenimodipine
03
Conditions
subarachnoid hemorrhage (SAH)
Beyond the preview
Go deeper on DRKS00015645.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00015645.